|
TRIM26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
6.55959997430955E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62525548574877E-12 |
| Stage1-vs-Stage2 |
4.072200E-01 |
| Stage1-vs-Stage3 |
6.341900E-03 |
| Stage1-vs-Stage4 |
1.419680E-02 |
| Stage2-vs-Stage3 |
1.253840E-02 |
| Stage2-vs-Stage4 |
9.779900E-03 |
| Stage3-vs-Stage4 |
7.716400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.10350000026571E-07 |
| Normal-vs-Asian |
1.71549999761211E-08 |
| Caucasian-vs-AfricanAmerican |
5.718200E-01 |
| Caucasian-vs-Asian |
1.888630E-01 |
| AfricanAmerican-vs-Asian |
7.329200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.936000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.88737914186277E-15 |
| Normal-vs-Age(61-80Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(81-100Yrs) |
1.24800000000924E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.916600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.484400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.603800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.316500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.004200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.822600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.432500E-04 |
| Classical-VS-Follicular |
3.942200E-01 |
| Classical-VS-Other |
2.662200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
6.918200E-03 |
| Tall-VS-Other |
4.909400E-01 |
| Tall-VS-Normal |
1.62614366416847E-12 |
| Follicular-VS-Other |
4.887400E-01 |
| Follicular-VS-Normal |
6.01485528051171E-12 |
| Other-VS-Normal |
1.73591999999001E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.66373598126302E-15 |
| Normal-vs-N1 |
3.05955261126201E-12 |
| N0-vs-N1 |
7.370100E-02 |
|
|
